XClinical GmbH's Dr. Philippe Verplancke Member of CDISC E3C

Published: Apr 24, 2009

MUNICH--(BUSINESS WIRE)--XClinical, a European vendor of innovative software products for eClinical trials, today announced the election of its CEO Dr. Philippe Verplancke as a member of the European CDISC Coordinating Committee (E3C). After a series of interviews with representatives of the industry, the current E3C members decided to appoint Dr. Philippe Verplancke. “I’m very happy to help promote the adoption of CDISC standards throughout Europe”, Dr. Verplancke pointed out.

Back to news